Last week, Alphabet Inc. GOOG GOOGL CEO Sundar Pichai revealed that the tech giant once came close to acquiring Netflix Inc. NFLX. What Happened: In a new interview on the All-In Podcast ...

In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOG) stands against other stocks Wall Street is talking about these days. Gene Muster from Deepwater Asset Management ...

Co-host David Friedberg asked the Alphabet leader whether his company was getting disrupted by aggressive peers that are competing in the AI space. "The dilemma only exists if you treat it as a ...

On the back of encouraging pronouncements about its ever-deepening involvement with artificial intelligence (AI), Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) two listed stocks both gained ground on ...

InvestigationBackless tops, head-to-toe flashy colors... On the red carpet, the French-American actor explores striking styles. Major brands are drawn to his fluidity and are eager to collaborate ...

“The only way forward for Alphabet is a complete breakup that would allow investors to own the business they actually want,” he wrote, adding that valuing the company on a sum-of-the-parts basis “only ...

Alphabet Inc. (GOOGL)’s strong “intellectual property and talent” will enable the tech giant to adapt effectively to the threat that it’s facing from AI chatbots, Jim Lebenthal, a partner ...

The Interstellar Enigma mission in Revenge of the Savage Planet won’t be easy to track. You’ll be contacted by a mysterious figure who mentions strange readings and frequencies. The key here ...

Alphabet Inc.’s quarterly results last week gave tech investors a bit a breather, after weeks of agita over the potential impact of the trade war — and all its day-to-day fluctuations — on ...

ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; enrollment to start imminently; 12-week study results expected in Q4 2026 ...

The issuer is solely responsible for the content of this announcement. Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with ...

Investing.com -- A full-scale breakup of Alphabet is the only way to unlock the tech giant’s true value, according to a new research note from DA Davidson. While maintaining a Neutral rating ...